Clinical Trials Directory

Trials / Completed

CompletedNCT02963740

Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer Survivors

Feasibility of High Levels of Energy Expenditure From Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
University of Kansas Medical Center · Academic / Other
Sex
Female
Age
71 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to demonstrate that breast cancer survivors who need to lose weight are able to follow a weight loss program which combines modest calorie restriction with a graduated activity program..

Detailed description

Feasibility will be assessed by 1) the number of women that complete the 3--month program; 2) the number of women that can achieve the targeted amount of physical activity per week by the end of the program; and 3) the median amount of physical activity achieved group by all subjects that complete the program.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSupervised ExerciseParticipants will take part in supervised exercise activities two times per week at a YMCA. Length of the activity will be increased during participation in study. Participants will start at 40 minutes per week and work their way up to 120 minutes per week.
BEHAVIORALHome-based ExerciseAerobic exercise activities to be completed at home. Participants will be asked to start out doing 60 minutes at home and work up to 180 minutes of purposeful aerobic home exercise per week.
BEHAVIORALGroup Phone CallsOnce weekly phone calls that are group-based. The calls will discuss lifestyle changes specific to participants and cover the effects of diet, physical activity, and weight on breast cancer risk, as well as body image and emotional eating.
BEHAVIORALDietParticipants will consume a nutritionally balanced, reduced calorie diet as recommended by the Academy of Nutrition and Dietetics.

Timeline

Start date
2016-11-01
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2016-11-15
Last updated
2022-01-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02963740. Inclusion in this directory is not an endorsement.